d-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review

By Galazis Nicolas   Galazi Myria   Atiomo William  

Gynecological Endocrinology, Vol. 27, Iss. 4, 2011-04 ,pp. : 256-262

Informa Healthcare

Access to resources Recommend Favorite

Effects of myo‐inositol on the in‐vitro maturation and subsequent development of mouse oocytes

By Chiu Tony Tak Yu   Rogers Michael Scott   Briton‐Jones Christine   Haines Christopher  

Human Reproduction, Vol. 18, Iss. 2, 2003-02 ,pp. : 408-416

Oxford University Press

Access to resources Recommend Favorite

Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients

By Genazzani Alessandro D.   Santagni Susanna   Rattighieri Erika   Chierchia Elisa   Despini Giulia   Marini Giulia   Prati Alessia   Simoncini Tommaso  

Gynecological Endocrinology, Vol. 30, Iss. 6, 2014-06 ,pp. : 438-443

Informa Healthcare

Access to resources Recommend Favorite

Myo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation induction

By Papaleo Enrico   Unfer Vittorio   Baillargeon Jean-Patrice   De Santis Lucia   Fusi Francesco   Brigante Claudio   Marelli Guido   Cino Ilaria   Redaelli Anna   Ferrari Augusto  

Gynecological Endocrinology, Vol. 23, Iss. 12, 2007-12 ,pp. : 700-703

Informa Healthcare

Access to resources Recommend Favorite

Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials

By Unfer V.   Carlomagno G.   Dante G.   Facchinetti F.  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 509-515

Informa Healthcare

Access to resources Recommend Favorite